Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Academic-Industrial Collaboration in Synthesis with Real-Time Impact in Medicinal Chemistry: Discovery of Cystic Fibrosis C2 Corrector ABBV-602.
Journal: ACS medicinal chemistry letters
Published: July 25, 2025
Neuroprotective Effects of σ2R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.
Journal: ACS chemical neuroscience
Published: September 15, 2022
σ2R/TMEM97 in retinal ganglion cell degeneration.
Journal: Scientific reports
Published: March 10, 2022
Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.
Journal: ACS chemical neuroscience
Published: November 14, 2018
High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model.
Journal: ACS chemical neuroscience
Published: February 11, 2018
Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: December 31, 2017
Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.
Journal: ACS medicinal chemistry letters
Published: February 15, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026